Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer

scientific article published in December 2017

Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CELREP.2017.11.104
P932PMC publication ID5747303
P698PubMed publication ID29281831

P50authorLanjing ZhangQ41729848
Robert L FullemQ59398168
Hiep TranQ59398181
Joshua K ThackrayQ61268468
Jinchuan XingQ74609479
Oscar Pellón-CárdenasQ84076918
Om A KothariQ95975031
P2093author name stringMichael P Verzi
Ansu O Perekatt
Anbo Zhou
Bailey N Warder
Emily E Fokas
Kevin Tong
Veerin R Sirihorachai
P2860cites workIntestinal polyposis in mice with a dominant stable mutation of the beta-catenin geneQ24529898
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesQ24536351
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationQ24627354
Comprehensive molecular characterization of human colon and rectal cancerQ24630415
Wnt/β-catenin signaling and diseaseQ26823272
Serrated lesions of the colorectum: review and recommendations from an expert panelQ26827208
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.Q27852431
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerQ27853326
A genetic model for colorectal tumorigenesisQ27860582
Fast gapped-read alignment with Bowtie 2Q27860699
Identification of stem cells in small intestine and colon by marker gene Lgr5Q28131701
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheQ28239639
APC mutations occur early during colorectal tumorigenesisQ28274764
Crypt stem cells as the cells-of-origin of intestinal cancerQ28304418
Cdx2 determines the fate of postnatal intestinal endodermQ28504729
Wnt proteins are lipid-modified and can act as stem cell growth factorsQ29615009
Cells of origin in cancerQ29619557
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cellsQ33589421
The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complexQ33615294
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersQ34280882
The intestinal crypt, a prototype stem cell compartmentQ34358606
An intestine-specific homeobox gene regulates proliferation and differentiationQ34370444
Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2Q34404177
Oncogenic Braf induces melanocyte senescence and melanoma in miceQ34974162
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patientsQ35045711
RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markersQ35095334
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumorsQ35649378
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinomaQ35774120
Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cellsQ35845010
Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1).Q36061304
CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancerQ36312135
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer SubtypeQ37086982
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.Q37608879
Role of the serrated pathway in colorectal cancer pathogenesisQ37737403
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsQ39166874
Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cellsQ39873345
The Intestinal Wnt/TCF Signature.Q40167195
V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4aQ42059658
Tissue-specific and inducible Cre-mediated recombination in the gut epitheliumQ44999476
Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imagingQ45716629
Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.Q50501238
Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.Q50642659
Visualization of a short-range Wnt gradient in the intestinal stem-cell niche.Q52885366
Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.Q53205541
Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.Q53260087
BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.Q54346395
Stroma provides an intestinal stem cell niche in the absence of epithelial WntsQ57002669
Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic miceQ74250578
Generation of Smad4/Dpc4 conditional knockout miceQ77668147
Molecular Genetics of Colorectal CancerQ82521439
P4510describes a project that usesImageJQ1659584
P433issue13
P921main subjectcolorectal cancerQ188874
P304page(s)3833-3845
P577publication date2017-12-01
P1433published inCell ReportsQ5058165
P1476titleDegree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer
P478volume21

Reverse relations

cites work (P2860)
Q93018032A model for RAS mutation patterns in cancers: finding the sweet spot
Q99566645A smooth muscle-derived, BRAF-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin
Q98463864BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Q93046337CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer
Q91564745Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Q55411157Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.
Q92331830Directional association test reveals high-quality putative cancer driver biomarkers including noncoding RNAs
Q91584962Identification of key candidate genes for colorectal cancer by bioinformatics analysis
Q50026745Metaplastic Cdx2-depleted cells can be very disruptive neighbors.
Q58776529Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Q93022810Recycling Endosomes in Mature Epithelia Restrain Tumorigenic Signaling
Q89480288SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium
Q91310933Serrated Colorectal Cancer: The Road Less Travelled?
Q50036749The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non-cell-autonomous mechanisms.
Q90608763Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells
Q98652622α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer

Search more.